Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 2
2(50.0%)
4Total
N/A(2)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07095478Phase 2Not Yet Recruiting

Safety and Efficacy of Oral Artesunate for Pre-cervical Cancer

Role: lead

NCT07095309Phase 2Not Yet Recruiting

Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/ III Colorectal Cancer

Role: lead

NCT05618483Not ApplicableUnknown

Xylitol Based Nasal Spray for COVID-19 Treatment

Role: collaborator

NCT02728739Not ApplicableCompleted

Incidence of Significant Mitral Regurgitation in Acute Heart Failure Patients

Role: lead

All 4 trials loaded